Author:
Guo Yadong,Jie Xiaoliang,Zhang Aihong,Zhang Wentao,Wang Ruiliang,Zhang Junfeng,Mao Shiyu,Wu Yuan,Wang Longsheng,Zhang Ziwei,Yan Yang,Wang Ping,Yao Xudong
Funder
National Natural Science Foundation of China
Reference16 articles.
1. Cancer statistics, 2019;Siegel;CA: A Cancer J Clin.,2019
2. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Alfred Witjes;Eur Urol.,2017
3. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer PJ;J Clin Oncol.,1992
4. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol.,2000
5. Immune checkpoint blockade in metastatic urothelial cancer;Balar;J Clin Oncol.,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献